Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-053858

Cascadian Therapeutics, Inc. · CASC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jun 12, 2014
Accepted (ET)
Jun 16, 2015 · 4:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001412067

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockJun 13, 2014M16,042$0.00A139,818D
Common StockF1Jun 13, 2014F4,011$3.88D135,807D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Share Units (RSU)F2,F3—Jun 12, 2014A12,886A——Common Stock12,88612,886D
Restricted Share Unit (RSU)F2,F4—Jun 13, 2015M16,042D——Common Stock16,0420D

Explanation of responses